Standard Article

Is there an advantage in using methotrexate in combination with non-biologic disease modifying anti-rheumatic drugs over methotrexate monotherapy in people with rheumatoid arthritis??

  1. David S. Edwards

Published Online: 10 SEP 2013

DOI: 10.1002/cca.201

Cochrane Clinical Answers

How to Cite

Is there an advantage in using methotrexate in combination with non-biologic disease modifying anti-rheumatic drugs over methotrexate monotherapy in people with rheumatoid arthritis?? David S. Edwards (on behalf of Cochrane Clinical Answers Editors). Cochrane Clinical Answers 2012. DOI: 10.1002/cca.201.

  1. CCA Associate editor: David S. Edwards, Assistant Professor, Department of Family & Community Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

  2. CCA Editor: Karen Pettersen. Correspondence to kpettersen@wiley.com.

Publication History

  1. Publication Status: Updated
  2. Published Online: 10 SEP 2013

SEARCH

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
    http://wiley.force.com/Interface/ContactJournalCustomerServices_V2.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >